MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr |
What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹2,413 Cr |
| Mar2024 | ₹2,152 Cr |
| Mar2023 | ₹1,813 Cr |
| Mar2022 | ₹920 Cr |
| Mar2021 | ₹1,137 Cr |
How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,413 Cr | 12.12 | |
| Mar2024 | ₹2,152 Cr | 18.70 | |
| Mar2023 | ₹1,813 Cr | 97.15 | |
| Mar2022 | ₹920 Cr | -19.12 | |
| Mar2021 | ₹1,137 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,729.6 Cr | 0.6% | 7.3% | 10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.6% |
7.3% |
10.3% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses